{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:47:06Z","timestamp":1784047626877,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jbspin.2012.08.004","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T05:31:29Z","timestamp":1352439089000},"page":"250-257","source":"Crossref","is-referenced-by-count":22,"title":["Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review"],"prefix":"10.1016","volume":"80","author":[{"given":"Guillaume","family":"Coiffier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bouvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florance","family":"Chopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Biver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Guggenbuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2012.08.004_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.moo.0000127830.72761.00","article-title":"Noninvasive techniques for assessing skeletal changes in inflammatory arthritis:bone biomarkers","volume":"16","author":"Garnero","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0010","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","article-title":"Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen","volume":"44","author":"Rosenquist","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0020","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women:the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0025","first-page":"389","article-title":"Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from UK, France, Belgium and the USA","volume":"29","author":"Glover","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1359\/jbmr.2001.16.9.1642","article-title":"Cross-sectional evaluation of bone metabolism in men","volume":"16","author":"Szulc","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0040","first-page":"1250","article-title":"Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis","volume":"26","author":"Al-Awadhi","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1749-6632.2002.tb04254.x","article-title":"Serum osteocalcin levels in premenopausal rheumatoid arthritis patients","volume":"966","author":"Seriolo","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00296-009-0867-x","article-title":"Serum concentrations of formation (PINP) and resorption (CTX) bone turnover markers in rheumatoid arthritis","volume":"29","author":"Wis\u0142owska","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0055","first-page":"153","article-title":"How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy","volume":"64","author":"Cortet","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00223-002-1024-7","article-title":"Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis","volume":"72","author":"Iwamoto","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1445-5994.2004.00647.x","article-title":"Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis","volume":"34","author":"Wong","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0070","first-page":"2201","article-title":"Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures","volume":"26","author":"Mitra","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard.54.7.556","article-title":"Evidence of impaired cartilage\/bone turnover in patients with active ankylosing spondylitis","volume":"54","author":"Marhoffer","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-8981(99)00170-9","article-title":"Biochemical markers of bone remodeling and bone sialoprotein in ankylosing spondylitis","volume":"289","author":"Acebes","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/rheumatology\/38.1.21","article-title":"Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis","volume":"38","author":"Toussirot","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s100670050024","article-title":"Biochemical bone turnover markers in patients with ankylosing spondylitis","volume":"19","author":"Yilmaz","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.61.1.92","article-title":"Osteocalcin: a marker of disease activity in ankylosing spondylitis?","volume":"61","author":"Falkenbach","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.62.4.347","article-title":"Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha","volume":"62","author":"Allali","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3349\/ymj.2008.49.2.288","article-title":"Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis","volume":"49","author":"Park","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/rheumatology\/ken148","article-title":"Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis","volume":"47","author":"Vosse","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0115","first-page":"2236","article-title":"Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis","volume":"31","author":"Franck","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0120","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/rheumatology\/kel072","article-title":"Elevated serum levels of soluble receptor activator of nuclear factors-kappa B ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS)","volume":"45","author":"Kim","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3349\/ymj.2002.43.4.435","article-title":"The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis","volume":"43","author":"D\u00edlek","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0130","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.20222","article-title":"Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis","volume":"50","author":"Landew\u00e9","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10165-006-0517-z","article-title":"The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis","volume":"16","author":"Torikai","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/rheumatology\/kei082","article-title":"Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study","volume":"44","author":"Lange","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/rheumatology\/kei280","article-title":"The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis","volume":"45","author":"Torikai","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0150","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","article-title":"Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NF\u03baB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis","volume":"65","author":"Vis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.2007.076604","article-title":"Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis","volume":"67","author":"Chopin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0160","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar2219","article-title":"A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab","volume":"9","author":"Marotte","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.jbspin.2012.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-008-0870-8","article-title":"Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis","volume":"27","author":"Yasunori","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0170","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2004.028670","article-title":"Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment","volume":"64","author":"Briot","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0175","first-page":"1753","article-title":"Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept","volume":"34","author":"Woo","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0180","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3823","article-title":"The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis:a prospective longitudinal observational cohort study","volume":"14","author":"Arends","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0185","first-page":"683","article-title":"Factors influencing bone loss in rheumatoid arthritis:a longitudinal study","volume":"18","author":"Cortet","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00774-004-0605-0","article-title":"Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis","volume":"23","author":"Nonaka","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00296-005-0608-8","article-title":"Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy","volume":"26","author":"Loddenkemper","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0200","first-page":"33","article-title":"Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis:a prospective study","volume":"24","author":"Lange","year":"2004","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00296-004-0496-3","article-title":"The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids:a comparison of alendronate and intranasal salmon calcitonin","volume":"26","author":"Tascioglu","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00198-005-0037-2","article-title":"Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone:a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Lems","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0215","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis:a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/39.9.1009","article-title":"Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study","volume":"39","author":"Aman","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0225","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.10616","article-title":"Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis:the COBRA study","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.08.004_bib0230","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.21896","article-title":"The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction","volume":"54","author":"Geusens","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T21:41:27Z","timestamp":1594849287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X12001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1297319X12001947"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2012.08.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}